Monoclonal Antibodies

News - Monoclonal Antibodies

Pharmacyclics® Announces Updated Results for BTK Inhibitor Ibrutinib (PCI-32765) at American Society of Clinical Oncology (ASCO) Annual Meeting

2012-06-04 06:27:11

Abstract # 6507: The Bruton's tyrosine kinase inhibitor PCI-32765 in treatment-naïve chronic lymphocytic leukemia patients: Interim results of a phase Ib/II study.

Marshall Edwards Presents Results From Clinical Trial Of Lead Oncology Drug Candidate ME-143

2012-06-04 02:26:56

SAN DIEGO, June 4, 2012 /PRNewswire/ -- Marshall Edwards, Inc.

Goodwin Biotechnology and MD Anderson Cancer Center Collaborate on the GMP Manufacturing of a Fusion Protein Conjugate that Potentially Represents a Critical Advance in Oncology

2012-06-04 02:26:37

PLANTATION, Fla. and HOUSTON, June 4, 2012 /PRNewswire/ -- Goodwin Biotechnology, Inc.

Alder Biopharmaceuticals to Present at Jefferies Global Healthcare Conference

2012-06-04 02:26:12

BOTHELL, Wash., June 4, 2012 /PRNewswire/ -- Alder Biopharmaceuticals Inc.

Afatinib*, Boehringer Ingelheim's investigational compound, demonstrates progression free survival of almost one year in patients with EGFR mutation positive, advanced non-small cell lung cancer in pivotal phase III trial

2012-06-04 02:25:40

LUX-Lung 3 trial results highlighted at the official ASCO Press Conference: Afatinib* delays lung cancer progression compared to standard chemotherapy BURLINGTON,

More News (5704 articles) »